Search results
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 2 days agoHe also highlighted that overall, there are 1,023 single country adoptive cell therapy clinical studies being run in the APAC region compared to 476 in...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 7 days agoOncological researchers suspect that disappointing treatment results can be the result of several circumstances, including poor quality of the CAR-T cell
CAR-T therapy achieves lupus remission breakthrough
BioPharma-Reporter· 21 hours agoThis is the first trial to date to show safe elimination of all autoantibodies in patients with systemic lupus erythematosus (SLE) and lupus nephritis...
Finding The Right Balance Of T Cell Expansion And Phenotype For Cell Therapy
BioresearchOnline· 3 days agoExplore this study that works to determine the optimal concentrations of IL-7 and IL-15 for T cell...
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 2 days agoThe “remarkable” success of chimeric antigen receptor T-cell therapy (CAR-T) in lupus has led to a...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 6 days agoNew research provides insight into ultra-rare case of secondary cancer in a patient who received CAR...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 2 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 6 days agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 2 days agoT cell therapy accounts for 55% of all adoptive cell therapy trials, according to data obtained ...